Professional
Added to YB: 2024-06-26
Pitch date: 2024-06-20
IQV [bullish]
IQVIA Holdings Inc.
-26.09%
current return
Author Info
No bio for this author
Company Info
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
Market Cap
$26.7B
Pitch Price
$215.31
Price Target
280.00 (+76%)
Dividend
N/A
Sector
Life Sciences Tools and Services
Category
growth
IQVIA Holdings Inc.: Strong new order flow
IQV: Buy. $280 PT. Strong Q1 order growth, 8.3% backlog rise. 1.26 book-to-bill ratio. 2024 guidance: $15.3-15.6B rev, 24-24.3% EBITDA margin, $10.95-11.25 EPS. 10% 5yr EPS CAGR. Leader in biopharma services, data analytics. Risks: competition, pharma R&D spending. Trades 17x 2025E EPS vs 21.8x peer avg.
Read full article (4 min)